Jonathan Kimball

May 26-27, 2021 | Virtual Conference

Register Today

Jonathan Kimball

Vice President, Trade & International Affairs
AAM

Jonathan Kimball is the Vice President of Trade and International Affairs at the Association for Accessible Medicines (AAM). He serves as senior strategist and advocate in partnership with the SVP, General Counsel, to direct the international trade strategy of AAM and represent the association and its member companies’ interests before the U.S. Trade Representative, the Department of Commerce, Congress, The White House and other stakeholders. He identifies public policy priorities and implements strategies to advance AAM’s trade and international affairs agenda.

Before joining AAM in February 2019, Jonathan was Managing Director, Healthcare Policy at Burson Cohn & Wolfe (formerly Burson-Marsteller). In this role he collaborated with pharmaceutical companies, medical device companies, trade associations and other clients to develop public affairs and advocacy campaigns aimed at influencing the policy and regulatory environments in the United States and international markets. Previously he was Deputy Vice President at Pharmaceutical Research and Manufacturers of America (PhRMA), for which he developed and advanced external advocacy and communication efforts in partnership with senior U.S. and foreign government officials, Congressional staff, patient organizations and other trade associations.

Jonathan’s earlier career took him to Budapest, Hungary, for Freedom House and other NGOs. He earned a master’s degree in International Affairs/International Political Economy from American University and a BA from San Francisco State University.

Get Started
& Register

Dividing Lines

Whether you are an AAM member, general attendee, or exhibitor, come meet the leaders and decision-makers who are determining the future of generics and biosimilars.

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

Access 2021 will use the information you provide on this form to be in touch with you and to provide updates and marketing.

Get Started
& Register

Dividing Lines

Whether you are an AAM member, general attendee, or exhibitor, come meet the leaders and decision-makers who are determining the future of generics and biosimilars.

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

Access 2021 will use the information you provide on this form to be in touch with you and to provide updates and marketing.
Skip to content